15.80Open15.80Pre Close0 Volume0 Open Interest35.00Strike Price0.00Turnover184.77%IV-4.23%PremiumDec 20, 2024Expiry Date16.58Intrinsic Value100Multiplier17DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9249Delta0.0207Gamma1.10Leverage Ratio-0.0273Theta-0.0099Rho-1.02Eff Leverage0.0056Vega
MediWound Stock Discussion
·3 mins ago
Mediwound Announces U.S. Food and Drug Administration Approval of Nexobrid® for the Treatment of Pediatric Patients With Severe Thermal Burns
No comment yet